ONC Oncolytics Biotech Inc
- 1.300
- -0.060-4.41%
Oncolytics Biotech Inc News
Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY), R1 RCM (RCM) and Lumos Pharma (LUMO)
Oncolytics Biotech (ONCY) Receives a Buy From RBC Capital
Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Oncolytics Biotech (ONCY) and Irhythm Technologies (IRTC)
Maxim Group Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Maintains Target Price $5
CCORF Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Maintains Target Price $5
Buy Rating on Oncolytics Biotech Backed by Strong Clinical Trials and Strategic Partnerships
Oncolytics Biotech Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)
Analysts Are Bullish on These Healthcare Stocks: Oncolytics Biotech (ONCY), Lineage Therap (LCTX)
Oncolytics Biotech Analyst Ratings
Buy Rating Affirmed on Oncolytics Biotech Amid Progress and Strategic Clinical Trials
Oncolytics Biotech Analyst Ratings
Oncolytics Biotech Analyst Ratings
Buy Rating for Oncolytics Biotech Amidst Promising Trials and Anticipated Partnerships
Oncolytics Biotech Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY), Rhythm Pharmaceuticals (RYTM) and Rigel (RIGL)
HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $5 Price Target
Oncolytics Biotech Analyst Ratings
HC Wainwright & Co. Maintains Buy on Oncolytics Biotech, Lowers Price Target to $5
Oncolytics Biotech Analyst Ratings
